Sun exposure rapidly reduces plasmacytoid dendritic cells and inflammatory dermal dendritic cells in psoriatic skin

British Journal of Dermatology

Volumn 165, Issue 4, 2011, Pages 792-801

  Heier, I ^a,b   Soyland E ^c   Krogstad, A L ^b,c   Rodriguez Gallego C ^d   Nenseter, M S ^a,e   Jahnsen, F L ^a,f  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b Department of Pediatrics ^*  (Norway)

^c Section for Climate Therapy   (Norway)

^d Lipid Clinic   (Norway)

^e Research Institute for Internal Medicine   (Norway)

^f Department of Immunology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD163 ANTIGEN; CD1C ANTIGEN; CD45RA ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MYXOVIRUS RESISTANCE PROTEIN A;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATORY DERMAL DENDRITIC CELL; MACROPHAGE; MALE; PHOTOTHERAPY; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; PSORIASIS; PSORIASIS SEVERITY INDEX; SKIN BIOPSY; SUN EXPOSURE;

ADULT; AGED; ANTIGENS, CD1; ANTIGENS, CD11; DENDRITIC CELLS; FEMALE; GLYCOPROTEINS; GTP-BINDING PROTEINS; HELIOTHERAPY; HUMANS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELLS; MACROPHAGES; MALE; MIDDLE AGED; PSORIASIS; SUNLIGHT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 80053542363     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2011.10430.x     Document Type: Article

References (40)

1. Lowes MA, Bowcock AM, Krueger JG,. Pathogenesis and therapy of psoriasis. Nature 2007; 445: 866-73.
2. Nickoloff BJ, Xin H, Nestle FO, et al. The cytokine and chemokine network in psoriasis. Clin Dermatol 2007; 25: 568-73. (Pubitemid 350103656)
3. Tzu J, Kerdel F,. From conventional to cutting edge: the new era of biologics in treatment of psoriasis. Dermatol Ther 2008; 21: 131-41. (Pubitemid 351499216)
4. Zaba LC, Krueger JG, Lowes MA,. Resident and 'inflammatory' dendritic cells in human skin. J Invest Dermatol 2009; 129: 302-8.
5. Nestle FO, Conrad C, Tun-Kyi A, et al. Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med 2005; 202: 135-43. (Pubitemid 41002916)
6. Yao Y, Richman L, Morehouse C, et al. Type I interferon: potential therapeutic target for psoriasis? PLoS ONE 2008; 3: e2737.
7. Lande R, Gregorio J, Facchinetti V, et al. Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide. Nature 2007; 449: 564-9. (Pubitemid 47525141)
8. Zaba LC, Fuentes-Duculan J, Steinman RM, et al. Normal human dermis contains distinct populations of CD11c+BDCA-1+ dendritic cells and CD163+FXIIIA+ macrophages. J Clin Invest 2007; 117: 2517-25. (Pubitemid 47494353)
9. Ochoa MT, Loncaric A, Krutzik SR, et al. 'Dermal dendritic cells' comprise two distinct populations: CD1+ dendritic cells and CD209+ macrophages. J Invest Dermatol 2008; 128: 2225-31.
10. Raki M, Tollefsen S, Molberg O, et al. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 2006; 131: 428-38. (Pubitemid 44142462)
11. Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol 2009; 129: 79-88.
12. Stratis A, Pasparakis M, Rupec RA, et al. Pathogenic role for skin macrophages in a mouse model of keratinocyte-induced psoriasis-like skin inflammation. J Clin Invest 2006; 116: 2094-104. (Pubitemid 44162318)
13. Wang H, Peters T, Kess D, et al. Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammation. J Clin Invest 2006; 116: 2105-14. (Pubitemid 44162319)
14. Marble DJ, Gordon KB, Nickoloff BJ,. Targeting TNFalpha rapidly reduces density of dendritic cells and macrophages in psoriatic plaques with restoration of epidermal keratinocyte differentiation. J Dermatol Sci 2007; 48: 87-101. (Pubitemid 47381571)
15. Wang H, Peters T, Sindrilaru A, et al. Key role of macrophages in the pathogenesis of CD18 hypomorphic murine model of psoriasis. J Invest Dermatol 2009; 129: 1100-14.
16. Schwarz T,. Mechanisms of UV-induced immunosuppression. Keio J Med 2005; 54: 165-71. (Pubitemid 43200930)
17. Poon TS, Barnetson RS, Halliday GM,. Sunlight-induced immunosuppression in humans is initially because of UVB, then UVA, followed by interactive effects. J Invest Dermatol 2005; 125: 840-6.
18. Ullrich SE,. Mechanisms underlying UV-induced immune suppression. Mutat Res 2005; 571: 185-205. (Pubitemid 40313441)
19. Søyland E, Heier I, Rodríguez-Gallego C, et al. Sun exposure induces rapid immunological changes in skin and peripheral blood in patients with psoriasis. Br J Dermatol 2011; 164: 344-55.
20. Fredriksson T, Pettersson U,. Severe psoriasis-oral therapy with a new retinoid. Dermatologica 1978; 157: 238-44. (Pubitemid 8387357)
21. Fitzpatrick TB,. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1988; 124: 869-71.
22. Nilsen LT, Søyland E, Krogstad AL,. Estimated ultraviolet doses to psoriasis patients during climate therapy. Photodermatol Photoimmunol Photomed 2009; 25: 202-8.
23. Farkas L, Beiske K, Lund-Johansen F, et al. Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol 2001; 159: 237-43. (Pubitemid 33704208)
24. Fah J, Pavlovic J, Burg G,. Expression of MxA protein in inflammatory dermatoses. J Histochem Cytochem 1995; 43: 47-52.
25. Simon A, Fah J, Haller O, et al. Interferon-regulated Mx genes are not responsive to interleukin-1, tumor necrosis factor, and other cytokines. J Virol 1991; 65: 968-71.
26. Aebi M, Fah J, Hurt N, et al. cDNA structures and regulation of two interferon-induced human Mx proteins. Mol Cell Biol 1989; 9: 5062-72. (Pubitemid 19275977)
27. Lowes MA, Kikuchi T, Fuentes-Duculan J, et al. Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 2008; 128: 1207-11. (Pubitemid 351543220)
28. Lowes MA, Chamian F, Abello MV, et al. Increase in TNF-alpha and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a). Proc Natl Acad Sci USA 2005; 102: 19057-62. (Pubitemid 43049565)
29. Gilliet M, Cao W, Liu YJ,. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol 2008; 8: 594-606.
30. Auffray C, Sieweke MH, Geissmann F,. Blood monocytes: development, heterogeneity, and relationship with dendritic cells. Annu Rev Immunol 2009; 27: 669-92.
31. Kölgen W, Both H, van Weelden H, et al. Epidermal Langerhans cell depletion after artificial ultraviolet B irradiation of human skin in vivo: apoptosis versus migration. J Invest Dermatol 2002; 118: 812-17. (Pubitemid 34526543)
32. Bechetoille N, Dezutter-Dambuyant C, Damour O, et al. Effects of solar ultraviolet radiation on engineered human skin equivalent containing both Langerhans cells and dermal dendritic cells. Tissue Eng 2007; 13: 2667-79. (Pubitemid 350076746)
33. Holtick U, Marshall SR, Wang XN, et al. Impact of psoralen/UVA-treatment on survival, activation, and immunostimulatory capacity of monocyte-derived dendritic cells. Transplantation 2008; 85: 757-66. (Pubitemid 351398254)
34. Rivas JM, Ullrich SE,. Systemic suppression of delayed-type hypersensitivity by supernatants from UV-irradiated keratinocytes. An essential role for keratinocyte-derived IL-10. J Immunol 1992; 149: 3865-71. (Pubitemid 23068866)
35. Maverakis E, Miyamura Y, Bowen MP, et al. Light, including ultraviolet. J Autoimmun 2010; 34: J247-57.
36. Aubin F,. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol 2003; 13: 515-23. (Pubitemid 38030789)
37. Loser K, Mehling A, Loeser S, et al. Epidermal RANKL controls regulatory T-cell numbers via activation of dendritic cells. Nat Med 2006; 12: 1372-9. (Pubitemid 44924495)
38. Menter A, Korman NJ, Elmets CA, et al. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2010; 62: 114-35.
39. El-Mofty M, Mostafa WZ, Bosseila M, et al. A large scale analytical study on efficacy of different photo(chemo)therapeutic modalities in the treatment of psoriasis, vitiligo and mycosis fungoides. Dermatol Ther 2010; 23: 428-34.
40. Johnson-Huang LM, Suarez-Farinas M, Sullivan-Whalen M, et al. Effective narrow-band UVB radiation therapy suppresses the IL-23/IL-17 axis in normalized psoriasis plaques. J Invest Dermatol 2010; 130: 2654-63.